JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended March 31, 2012. Net revenues of $5.1 billion, compared to $4.1 billion in the first quarter of 2011, an increase of 25%.
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter ended March 31, 2012. Net revenues of $5.1 billion, compared to $4.1 billion in the first quarter of 2011, an increase of 25%.
